MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Inovio Pharmaceuticals Company Profile (NASDAQ:INO)

Consensus Ratings for Inovio Pharmaceuticals (NASDAQ:INO) (?)
Ratings Breakdown: 6 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.33 (121.15% upside)

Analysts' Ratings History for Inovio Pharmaceuticals (NASDAQ:INO)
Show:
DateFirmActionRatingPrice TargetActions
6/21/2016Maxim GroupReiterated RatingBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016Rodman & RenshawReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/21/2016HC WainwrightReiterated RatingBuy$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Stifel NicolausReiterated RatingBuy$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/14/2016Brean CapitalLower Price TargetBuy$20.00 -> $18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/21/2016Piper JaffrayReiterated RatingOverweight$31.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/24/2014AegisUpgradeHold -> Buy$10.00 -> $19.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/28/2014 forward)
Earnings History for Inovio Pharmaceuticals (NASDAQ:INO)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/8/2016        
5/9/2016Q1($0.14)($0.11)$4.75 million$8.10 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/14/2016Q4($0.20)($0.25)$6.96 million$5.94 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q3$0.04$0.07$1.84 million$24.18 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/10/2015Q215($0.13)($0.10)$5.52 million$5.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/11/2015Q1($0.11)($0.18)$7.04 million$5.20 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/16/2015Q414($0.10)($0.12)$5.24 million$2.50 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/10/2014Q314($0.14)($0.12)$5.60 million$1.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/11/2014Q214($0.19)($0.18)$1.80 million$3.80 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/12/2014Q114($0.04)($0.05)$1.41 million$2.40 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/17/2014Q413($0.03)($0.04)$1.36 million$1.70 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/11/2013Q3($0.02)($0.16)$2.99 million$9.50 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2012Q312($0.05)($0.05)$2.07 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Inovio Pharmaceuticals (NASDAQ:INO)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Inovio Pharmaceuticals (NASDAQ:INO)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Inovio Pharmaceuticals (NASDAQ:INO)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/18/2016Simon X BenitoDirectorSell6,250$10.37$64,812.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2016Morton CollinsDirectorBuy68,400$9.52$651,168.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/30/2015Niranjan SardesaiCOOBuy4,000$5.50$22,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/14/2015Simon X BenitoDirectorBuy6,000$7.21$43,260.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/13/2015Angel CabreraDirectorBuy8,000$9.53$76,240.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/9/2014Peter KiesCFOBuy3,960$10.10$39,996.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/21/2014Morton CollinsDirectorBuy8,000$10.01$80,080.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2014Morton CollinsDirectorBuy40,600$9.74$395,444.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Jong Joseph KimCEOBuy250,000$9.06$2,265,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/12/2014Niranjan SardesaiCOOBuy2,550$8.70$22,185.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/15/2014Jong Joseph KimCEOBuy25,000$2.25$56,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2013Morton CollinsDirectorBuy254,500$1.82$463,190.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2013Mark BagarazziInsiderBuy60,000$0.56$33,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/2/2013Jong Joseph KimCEOBuy90,000$0.50$45,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/22/2013Angel CabreraDirectorBuy40,000$0.54$21,600.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2013Jong Joseph KimCEOBuy60,000$0.53$31,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/20/2013Niranjan SardesaiCOOBuy25,000$0.53$13,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2013Morton CollinsDirectorBuy100,000$0.67$67,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/14/2012Austin W & Greenhouse Da MarxeMajor ShareholderSell622,550$0.53$329,951.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/15/2012Angel CabreraDirectorBuy75,000$0.59$44,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Inovio Pharmaceuticals (NASDAQ:INO)
DateHeadline
06/26/16 04:02 PMStock Sentiment Review for :Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Press Telegraph
06/26/16 04:02 PMActive Stock Performance : Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Press Telegraph
06/24/16 04:41 PMImpact Score Outlook on:Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Press Telegraph
06/24/16 04:41 PMStocks inside Analysts Limelight: Merck & Company, Inc. (NYSE:MRK) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/24/16 07:15 AMHC Stocks Updates: Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA), Inovio Pharmaceuticals Inc (NASDAQ:INO) - share market updates (press release)
06/24/16 07:15 AMInovio Pharmaceuticals Inc. (INO) Drops 9.41% on June 22 - Equities.com
06/23/16 04:58 PMZika Vaccine Ready for Human Trials
06/23/16 07:33 AMIntraday Movers - Inovio Pharmaceuticals, (NASDAQ:INO), Cadence Design Systems, (NASDAQ:CDNS) - Hot Stocks Point
06/23/16 07:33 AMInovio Pharmaceuticals Inc. (INO) is Trading Higher on Unusual Volume for June 21 - Equities.com
06/23/16 07:33 AMInovio Continues To Rally, But Hits Resistance - Benzinga
06/23/16 07:33 AMAnalyst's Noticeable Buzzers: Exelixis, Inc. (NASDAQ:EXEL) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/23/16 07:33 AMInovio Pharmaceuticals (INO) Highlighted As Weak On High Volume - TheStreet.com
06/22/16 04:44 PMWoodlands co. helped produce first Zika virus vaccine to be tested in humans (Video)
06/22/16 04:44 PMInovio Pharmaceuticals Inc (NASDAQ:INO) Jumps Ahead Of Sanofi (SNY) In Zika Vaccine Program
06/22/16 09:18 AMInovio Continues To Rally, But Hits Resistance
06/21/16 04:20 PMStocks on Hotspot- Caterpillar (NYSE:CAT), Inovio Pharmaceuticals (NASDAQ:INO), Viavi Solutions (NASDAQ:VIAV) - Seneca Globe
06/21/16 04:20 PMRodman & Renshaw Weighs In On Inovio Pharmaceuticals, Inc. (INO) As It Leads The Way To Fight Zika - Smarter Analyst
06/21/16 03:11 PMInovio Pharmaceuticals (INO) Optimistic on Zika/Ebola Vaccine Progress -
06/21/16 02:57 PMWe can rapidly move Zika and other vaccine studies forward: Inovio CEO -
06/21/16 01:15 PMLeading the fight against Zika -
06/21/16 12:06 PM[$$] Inovio Zika Vaccine Clear for Human Study -
06/21/16 09:11 AMInovio Pharma, GeneOne Life Science receive approval for phase I human trial of Zika vaccine, GLS-5700
06/21/16 09:11 AMPhase I Human Trial of Zika Vaccine Approved
06/21/16 09:11 AMInovio Pharmaceuticals and GeneOne Life Science Receive Approval for First-in-Man Zika Vaccine Clinical Trial
06/21/16 09:11 AMInovio Pharmaceuticals gets green light to trial Zika vaccine
06/21/16 09:11 AMInovio Pharmaceuticals Inc (INO) Options Hot On Zika Approval
06/21/16 08:05 AMHow Inovio Pharmaceuticals Is Leading the Zika Vaccine Race -
06/20/16 04:27 PMInovio Pharmaceuticals, Inc. Stock Momentum Hits Strength - CML News
06/20/16 04:27 PMInovio Pharmaceuticals Inc (INO) Options Hot On Zika Approval - Schaeffers Research (blog)
06/20/16 01:37 PMETF’s with exposure to Inovio Pharmaceuticals, Inc. : June 20, 2016 -
06/20/16 12:28 PMCNBC update: Orlando shooter 911 transcript -
06/20/16 09:22 AMStrong Buy Calls Count For Inovio Pharmaceuticals, Inc. (NASDAQ:INO) At 5 - Investor Newswire
06/20/16 08:10 AMHow Inovio Pharma Is Joining the Fight Against the Zika Virus -
06/19/16 08:49 AMBRIEF-Inovio Pharmaceuticals says stock offering of up to $50 mln - SEC Filing - Reuters
06/18/16 09:02 AMINOVIO PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
06/17/16 04:33 PMTake a look at Price Fluctuations: Endologix, Inc. (NASDAQ:ELGX) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/17/16 04:12 PMINOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and -
06/17/16 11:05 AMInovio Pharmaceuticals, Inc. – Value Analysis (NASDAQ:INO) : June 17, 2016 -
06/17/16 07:24 AMBetter Buy: Intrexon Corporation vs. Inovio Pharmaceuticals Inc. - Motley Fool
06/16/16 04:44 PMWill You Buy These Stocks? - J. C. Penney Company, Inc. (NYSE:JCP), Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Beacon Chronicle
06/15/16 04:41 PMYesterday Trading Recap: Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) , Inovio Pharmaceuticals, Inc ... - Street Updates
06/14/16 04:31 PMBuy or Sell These Stocks? - Inovio Pharmaceuticals, Inc. (NASDAQ:INO), Steris Plc (NYSE:STE) - Beacon Chronicle
06/14/16 03:36 PMThese Companies Prove that Reverse Splits Can Be a Very Good Thing for Stakeholders -
06/14/16 09:28 AMLatest Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Target Price Suggests Stock Is Worth $15.5/Share
06/13/16 04:21 PMBest Stocks for Investors: YY Inc. (NASDAQ:YY), Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Beacon Chronicle
06/10/16 04:51 PMPrice Fluctuations to Observe: Inovio Pharmaceuticals, Inc. (NASDAQ:INO) , Vertex Pharmaceuticals Incorporated ... - Street Updates
06/07/16 04:48 PMStocks within Traders Radar: Neothetics, Inc. (NASDAQ:NEOT) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/07/16 04:39 PMETF’s with exposure to Inovio Pharmaceuticals, Inc. : June 7, 2016 -
06/06/16 04:34 PMStocks inside Analysts Spotlight: CVS Health Corporation (NYSE:CVS) , Inovio Pharmaceuticals, Inc. (NASDAQ:INO) - Street Updates
06/06/16 04:34 PMEarnings Trend of the Stocks: Inovio Pharmaceuticals, Inc. (INO), RLJ Lodging Trust (RLJ) - Beacon Chronicle
About Inovio Pharmaceuticals

Inovio Pharmaceuticals logoInovio Pharmaceuticals, Inc. (Inovio) is a bio-pharmaceutical company, which is involved in developing deoxyribonucleic acid (DNA) immunotherapies and vaccines focused on treating and preventing cancers and infectious diseases. The Company's DNA-based immunotherapies, in combination with its electroporation delivery devices, generates immune responses, in particular T cells, in the body to fight target diseases. It has completed, current or planned clinical programs of its SynCon immunotherapies for human papillomavirus (HPV)-caused pre-cancers and cancers, breast/lung/pancreatic cancer, hepatitis C virus (HCV), hepatitis B virus (HBV), human immunodeficiency virus (HIV), influenza, Ebola, Middle East respiratory syndrome (MERS) and Zika virus. With its immunotherapy platform, as well as with its CELLECTRA electroporation delivery technology, the Company has a pipeline of pre-clinical and clinical stage products that have generated in vivo (in the body) immune responses.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: INO
  • CUSIP:
Key Metrics:
  • Previous Close: $8.29
  • 50 Day Moving Average: $10.45
  • 200 Day Moving Average: $8.11
  • P/E Ratio: N/A
  • P/E Growth: 0.00
  • Market Cap: $605.97M
  • Current Quarter EPS Consensus Estimate: $-0.75 EPS
Additional Links:
Inovio Pharmaceuticals (NASDAQ:INO) Chart for Tuesday, June, 28, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha